Reported value$242K3,000 shares at $80.67
For this personUnusual1 buy · 0 sales on file
Similar buys beat S&P46%1,159 cases · all buys 46%
Worth a closer look
- Open-market purchase with their own money (Form 4 code P), not a grant or option exercise.
- Raised their own holding by 1181%.
Reasons for caution
- Other insiders sold $2.3M in the same 90 days, more than was bought.
- Similar past buys beat the S&P 500 only 46% of the time (1,159 cases); the typical one trailed it by 1.8%.
- Their past buys: only 0 of 3 beat the S&P 500.
What happened after this filing
7 days
Pending
due Nov 4
30 days
Pending
due Nov 27
90 days
Pending
due Jan 26
Insider Twins: past buys with the same traits
1 insider buying · no CEO or CFO · under $250K · stock down 20%+ in 3 months
OGEN Nov 25, 2020 +185.0% vs S&PCDIO Sep 5, 2023 +167.8% vs S&PSAH Mar 23, 2020 +163.2% vs S&PADTX Apr 23, 2026 -105.7% vs S&PAVTX May 8, 2023 -102.0% vs S&PIPW Jul 9, 2026 -96.6% vs S&PWhat we couldn't check
- Why they traded. Filings don't say, and we don't guess.
- Company news after the filing, and any private terms.
Summary
Neal J. Keating (a director) bought $242K of HXL at about $80.67 on Oct 26, 2026, reported to the SEC on Oct 28, 2026. Buys like this beat the S&P 500 46% of the time since 2020, against 46% for all insider buys. We found 2 points that make it worth a closer look and 3 reasons for caution. History, not a prediction.
Following. We'll keep this page updated; see everything you follow. Want an email when the 30 and 90-day results land? Use the HXL alerts below.
Written by fixed rules from SEC filings and our measured history, not by an AI model. Public data only. History, not a prediction, and not investment advice.